Merz buying Mesa medical device company Ulthera for $600M

Merz, the German pharmaceutical company Merz that has its U.S.headquarters in North Carolina, has agreed to buy Arizona medical device company Ulthera for $600 million in upfront cash and milestone payments. That would be the largest deal yet for the fast-growing Merz, which makes products for the aesthetics, dermatology and neurosciences markets. Among its products are dermal fillers Radiesse and Belotero and Xeomin, a competitor to Botox. Ulthera is also in the aesthetics niche, but as a medical…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: research